BioNTech Se

(NASDAQ) BNTX

Current Price$94.28

Market Cap$23.80B

Since IPO (2019)+567%

5 Year-48%

1 Year-1%

1 Month+2%

BioNTech Se Financials at a Glance

Market Cap

$23.80B

Revenue (TTM)

$2.80B

Net Income (TTM)

$1.26B

EPS (TTM)

$-5.87

P/E Ratio

-16.03

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$94.28

Volume

35,688

Open

$93.21

Price

$94.28

Volume

35,688

Open

$93.21

Previous Close

$94.28

Daily Range

$92.64 - $95.76

52-Week Range

$79.52 - $124.00

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$94.28

Volume

35,688

Open

$93.21

Previous Close

$94.28

Daily Range

$92.64 - $95.76

52-Week Range

$79.52 - $124.00

BNTX News

A biotech lab technician using multiple pipettes to load blood samples into test tubes.

Why BioNTech Stock Soared Today

Rich SmithJun 2, 2025

Page 1

BNTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioNTech Se

Industry

Biotechnology

Sector

Health Care

Employees

7,807

CEO

Ugur Sahin, MD

Website

www.biontech.de

Headquarters

Mainz, 55131, DE

BNTX Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-46%

Net Income Margin

-40%

Return on Equity

-7%

Return on Capital

-7%

Return on Assets

-5%

Earnings Yield

-6.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$23.80B

Shares Outstanding

252.88M

Volume

35.69K

Avg. Volume

1.12M

Financials (TTM)

Gross Profit

$2.14B

Operating Income

$623.87M

EBITDA

$256.17M

Operating Cash Flow

$438.00M

Capital Expenditure

$168.19M

Free Cash Flow

$269.81M

Cash & ST Invst.

$14.83B

Total Debt

$267.29M

BioNTech Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$120.04M

-34.3%

Gross Profit

$75.83M

-176.6%

Gross Margin

-63.17%

N/A

Market Cap

$23.80B

N/A

Market Cap/Employee

$3.51M

N/A

Employees

6,772

N/A

Net Income

$540.65M

-30.0%

EBITDA

$548.68M

-48.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$14.35B

+3.9%

Accounts Receivable

$612.84M

-40.3%

Inventory

$103.91M

-59.2%

Long Term Debt

$246.36M

+3.7%

Short Term Debt

$56.76M

+2.3%

Return on Assets

-5.15%

N/A

Return on Invested Capital

-6.62%

N/A

Free Cash Flow

$485.66M

+67.0%

Operating Cash Flow

$427.92M

+47.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

UTHRUnited Therapeutics Corporation

UTHRUnited Therapeutics Corporation$564.94-0.74%

DXCMDexCom, Inc.

DXCMDexCom, Inc.$60.61-0.49%

RPRXRoyalty Pharma plc

RPRXRoyalty Pharma plc$50.79+1.18%

PHGKoninklijke Philips N.V.

PHGKoninklijke Philips N.V.$27.21+0.18%

STESTERIS plc

STESTERIS plc$207.45-2.92%

NTRANatera, Inc.

NTRANatera, Inc.$194.24-11.64%

INCYIncyte Corporation

INCYIncyte Corporation$98.56+0.81%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

NOKNokia

NOKNokia$12.82+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.35+0.01%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.01+0.26%

Questions About BNTX

What is the current price of BioNTech Se?

BioNTech Se is trading at $94.28 per share.

What is the 52-week range for BioNTech Se?

Over the past 52 weeks, BioNTech Se has traded between $79.52 and $124.00.

How much debt does BioNTech Se have?

As of the most recent reporting period, BioNTech Se reported total debt of $348.89M.

How much cash does BioNTech Se have on hand?

BioNTech Se reported $11.45B in cash and cash equivalents in its most recent financial results.

What is BioNTech Se’s dividend yield?

BioNTech Se does not currently have a dividend yield.

BioNTech Se

BioNTech Se Financials at a Glance

BNTX News

Best Biotech Stocks to Buy in 2026 and How to Invest in Them

Best Vaccine Stocks of 2026: Are They Right for Your Portfolio?

Why BioNTech Stock Is Getting Crushed Today

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

Why BioNTech Stock Bumped Higher Today

Why BioNTech Stock Sank by More Than 7% Today

Why BioNTech Stock Crushed the Market Today

Why BioNTech Stock Soared Today

BNTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioNTech Se

BNTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioNTech Se Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BNTX

What is the current price of BioNTech Se?

What is the 52-week range for BioNTech Se?

How much debt does BioNTech Se have?

How much cash does BioNTech Se have on hand?

What is BioNTech Se’s dividend yield?

Premium Investing Services